Everything we publish is free to read, download and reuse. Gifts pay for the curation, computing and publication fees that keep it current. A gift never unlocks content: data, tools and safety information stay free for everyone.
| Component | What it delivers | Rough cost |
|---|---|---|
| Biomarker atlas, one condition | Literature-grounded marker set with directions, comparison groups and sources, plus the atlas page | €300–800 in compute and curation time |
| Open-access publication fee | One peer-reviewed paper free to read for everyone, forever | €1,500–3,000 |
| Gene-target panel for ten conditions | Druggable targets and candidate compounds, graded, with trials linked | €1,000–2,000 |
| DecenTrial (beta → release) | Decentralised trial builder with standardised intervention and biomarker packages | €15,000–25,000 |
| Post-viral biobank, pilot | Standardised sample collection and clinical annotation for one cohort | €40,000–80,000 |
| Keeping the lights on | Hosting, registries, daily pipelines and corrections for a year | €3,000–5,000 |
Spotted an error or a missing trial? Tell us; every correction is credited.
Link to the Research Tracker or add the embed widget to your site.
Our research notes explain the evidence in plain language for patients and clinicians.